Royal Bank of Canada
WHWK

Royal Bank of Canada’s Whitehawk Therapeutics WHWK Stock Holding History

Royal Bank of Canada’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
+177
New +$554 ﹤0.01% 7004
2025
Q1 		– Sell
-40,000
Closed -$126K – 7356
2024
Q4 		$126K Buy
+40,000
New +$90.6K ﹤0.01% 5192
2024
Q3 		– Sell
-917
Closed -$1K – 7611
2024
Q2 		$1K Buy
917
+547
+148% +$1.01K ﹤0.01% 6936
2024
Q1 		$1K Sell
370
-3,819
-91% -$7.36K ﹤0.01% 6898
2023
Q4 		$8K Buy
4,189
+1,105
+36% +$4.64K ﹤0.01% 6569
2023
Q3 		$15K Buy
3,084
+341
+12% +$1.98K ﹤0.01% 6295
2023
Q2 		$19K Buy
2,743
+1,908
+229% +$14.8K ﹤0.01% 6251
2023
Q1 		$6K Sell
835
-1,234
-60% -$13.2K ﹤0.01% 6524
2022
Q4 		$27K Buy
2,069
+1,892
+1,069% +$24.7K ﹤0.01% 6186
2022
Q3 		$3K Buy
177
+96
+119% +$1.26K ﹤0.01% 6940
2022
Q2 		$1K Sell
81
-2,795
-97% -$41.5K ﹤0.01% 7233
2022
Q1 		$49K Buy
+2,876
New +$55.1K ﹤0.01% 6124

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Royal Bank of Canada's WHWK Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Whitehawk Therapeutics (WHWK) in Q1 2026: 177 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #7004 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in WHWK as recently as Q4 2024.

Royal Bank of Canada first reported a position in WHWK in Q1 2022 and has held it in 12 quarters since. The position peaked at $126K in Q4 2024. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Royal Bank of Canada held 177 shares of Whitehawk Therapeutics worth $1K as of Q1 2026.
  • Whitehawk Therapeutics was a new Royal Bank of Canada position in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7004 holding.
  • Royal Bank of Canada first reported a position in Whitehawk Therapeutics in Q1 2022 and has held it in 12 quarters since.
  • Royal Bank of Canada's Whitehawk Therapeutics position peaked at $126K in Q4 2024.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.